Proteomics Market Scope, Future Trends With Fastest Growing Regions And Countries Report 2022-2031


(MENAFN- America News Hour)

The proteomics market is projected to grow at a CAGR of 14.1% during the forecast period (2022 – 2031).

The proteomic market is projected to reach US $ 38.7 billion by 2031 from US $ 19.5 billion in 2022., CAGR is 14.7%. Increasing research activity, especially in the areas of personalized medicine and drug discovery, is a major growth driver for this market. In addition, increased R & D spending by pharmaceutical and biotechnology companies, increased government funding and technological advances are also driving the growth of the proteomics market . The growing excellence of nanoproteomics and personalized proteomics for precision health offers significant growth opportunities for players in this market. However, low biomarker discovery-to-approval ratios and data management in proteomics studies are some of the key challenges in the market.
“The protein fraction segment is expected to grow at the highest rate during the forecast period.”

Based on instrumentation technology, the proteomics market is segmented into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, and protein fractionation. The protein fraction segment is projected to witness the highest growth in the proteomics market during the forecast period. This growth is due to the benefits of protein fractionation, including the ability to effectively separate thousands of proteins in complex structures. The need for analysis of complex mixtures containing proteins is increasing in proteomics studies. It plays a role in driving market demand for protein fractionation systems:
“The bioinformatics software & services segment is expected to grow at the highest CAGR during the forecast period.”

Based on services and software, the proteomics market is segmented into core proteomics services and bioinformatics software & services. The Bioinformatics Software & Services segment is expected to witness the highest growth rates during the forecast period. With exponential growth in protein sequence and structure determination through genomic sequencing and structural genomics efforts, there is an increasing need for reliable computational methods to determine the biochemical function of these proteins. This is expected to drive growth in the bioinformatics segment over the next few years.

Download The Sample PDF Report Here For More Insights:
“The Asia-Pacific region is expected to witness the highest growth during the forecast period.”

North America is the largest in the global proteomics market in 2018. The Asia-Pacific region is expected to witness the highest CAGR during the forecast period, although it is expected to occupy a share of the market. Expanding scientific foundations and capabilities in Asia, growing proteomics and genomics research, increasing research funding, increasing investment by pharmaceutical and biotechnology companies, increasing awareness of personalized treatment, and research activities in the field of mAb-based treatment Increases are a driver of growth in this regional segment.

Below is a breakdown of the key participants mentioned in this report:

  • By company type: Tier 1 to 48%, Tier 2 to 34%, Tier 3 to 18%
  • Designation: C level 42%, director level 40%, Others 18%
  • By Region: North America-38%, Europe-25%, Asia Pacific-30%, Latin America-5%, Middle East / Africa-2%

Prominent players in the proteomics market are Thermo Fisher Scientists Fick (USA), Azilent Technologies (USA), GE Healthcare (USA), Bioradra Voluntaries (USA), Danahar Corporation (USA), Luminex Corporation (USA), Bullker Corporation (USA), Merck KGaA, (Germany) , Waters Corporation (USA), PerkinElmer (USA), Creative Proteomics (USA), Promega Corporation (USA).

Scope of the study:

This report analyzes the markets for various clinical workflow solutions and their adoption patterns. The aim is to estimate the market size and future growth potential of the proteomics market and various segments such as instrumentation technology, reagents, services and software, and applications. This report also includes a detailed competitive analysis of the major players in this market, their company profile, product and service offerings, and recent developments.
Reasons to buy the report

This report is not only for existing companies but also for existing companies. New entrants / SMEs will also be enriched to measure the beating of the market and, as a result, help them gain a larger share. Companies purchasing this report can use one or a combination of the following five strategies to enhance their market presence:

Click Here To Get The Sample PDF Report:
This report provides insights on the following pointers:

  • Market penetration: Comprehensive information on the product portfolio provided by the top players in the proteomics market.
  • Product & Service Development / Innovation: Detailed insights into future trends, R & D activities, and product or service launches in the proteomics market.
  • Market Development: Comprehensive information on profitable emerging regions
  • Market diversification: Extensive information on new products and services, growing regions, and recent developments in the global proteomics market
  • Competitive assessment: Market share of key players in the proteomics market, Growth strategy, profit analysis, and detailed evaluation of products and services.

About SDKI :

The dynamic nature of the business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count ( SDKI ) provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

MENAFN25092022004545010068ID1104920518


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.